These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29856752)

  • 1. Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis.
    Hosny KM; Rizg WY
    PLoS One; 2018; 13(6):e0197540. PubMed ID: 29856752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability.
    Hosny KM
    PLoS One; 2016; 11(5):e0154926. PubMed ID: 27148747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization and evaluation of tinidazole-loaded mPEG-PDLLA (10/90) in situ gel forming system for periodontitis treatment.
    Tian Y; Shen Y; Jv M
    Drug Deliv; 2016 Oct; 23(8):2726-2735. PubMed ID: 26289210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA
    Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alendronate-loaded, biodegradable smart hydrogel: a promising injectable depot formulation for osteoporosis.
    Nafee N; Zewail M; Boraie N
    J Drug Target; 2018 Aug; 26(7):563-575. PubMed ID: 29073792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats.
    Ahmed TA; Mussari MA; Abdel-Hady SE; El-Say KM
    Drug Des Devel Ther; 2019; 13():4035-4051. PubMed ID: 31839704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis.
    Hosny KM; Ahmed OA; Al-Abdali RT
    Expert Opin Drug Deliv; 2013 Jun; 10(6):741-6. PubMed ID: 23656470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
    Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
    Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of polycaprolactone on alendronate drug release from Mg-doped hydroxyapatite coating on titanium.
    Bose S; Vu AA; Emshadi K; Bandyopadhyay A
    Mater Sci Eng C Mater Biol Appl; 2018 Jul; 88():166-171. PubMed ID: 29636132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model.
    Bae J; Park JW
    Int J Pharm; 2015 Mar; 480(1-2):37-47. PubMed ID: 25595570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment.
    Jing C; Li B; Tan H; Zhang C; Liang H; Na H; Chen S; Liu C; Zhao L
    ACS Appl Bio Mater; 2021 Jun; 4(6):4907-4916. PubMed ID: 35007039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
    Sayed EG; Hussein AK; Khaled KA; Ahmed OA
    Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.
    Jiang Y; Zhang X; Mu H; Hua H; Duan D; Yan X; Wang Y; Meng Q; Lu X; Wang A; Liu W; Li Y; Sun K
    Drug Deliv; 2018 Nov; 25(1):143-152. PubMed ID: 29275639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
    Morsi N; Ghorab D; Refai H; Teba H
    Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
    Singh J; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication, assessment, and optimization of alendronate sodium nanoemulsion-based injectable
    Abdulaal WH; Hosny KM; Alhakamy NA; Bakhaidar RB; Almuhanna Y; Sabei FY; Alissa M; Majrashi M; Alamoudi JA; Hazzazi MS; Jafer A; Khallaf RA
    Drug Deliv; 2023 Dec; 30(1):2164094. PubMed ID: 36588399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.